APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Reproductive and Respiratory Syndrome Vaccine

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Selected research

Industry Research

Swine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2026

30 December 2025138 pages

Choose your research edition.

Industry ResearchSwine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Reproductive and Respiratory Syndrome Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Boehringer ingelheim is the company with the largest market share, about 25 percent.

Report Scope

Read the full market overview

This report quantifies the global Swine Reproductive and Respiratory Syndrome Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Swine Reproductive and Respiratory Syndrome Vaccine Market by Company

ASCENT CORPORATION

Boehringer-Ingelheim

MSD Animal Health

SPAH

Ceva

Chengdu TECH-BANK Biological Products Co,.Ltd

ringpu

QILU ANIMAL HEALTH PRODUCTS CO.,LTD

DAHUANONG

CAVAC

Komipharm

Agrovet

Bioveta

JINYU BIO-TECNOLOGY CO.,LTD

Phibro Animal Health

ANHUI TIANKANG(GROUP)SHRES O., LTD

Zoetis

WINSUN BIO

PULIKE BIOLOGICAL ENGINERING,INC.

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type

Active Vaccine

Inactivated Vaccines

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application

Government Tender

Market Sales

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Reproductive and Respiratory Syndrome Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Reproductive and Respiratory Syndrome Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Reproductive and Respiratory Syndrome Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Swine Reproductive and Respiratory Syndrome Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Swine Reproductive and Respiratory Syndrome Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Product Type & Application Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ASCENT CORPORATION Company Information Table 19. ASCENT CORPORATION Business Overview Table 20. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 22. ASCENT CORPORATION Recent Developments Table 23. Boehringer-Ingelheim Company Information Table 24. Boehringer-Ingelheim Business Overview Table 25. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 27. Boehringer-Ingelheim Recent Developments Table 28. MSD Animal Health Company Information Table 29. MSD Animal Health Business Overview Table 30. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 32. MSD Animal Health Recent Developments Table 33. SPAH Company Information Table 34. SPAH Business Overview Table 35. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 37. SPAH Recent Developments Table 38. Ceva Company Information Table 39. Ceva Business Overview Table 40. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 42. Ceva Recent Developments Table 43. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information Table 44. Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview Table 45. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 47. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments Table 48. ringpu Company Information Table 49. ringpu Business Overview Table 50. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 52. ringpu Recent Developments Table 53. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information Table 54. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview Table 55. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 57. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments Table 58. DAHUANONG Company Information Table 59. DAHUANONG Business Overview Table 60. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 62. DAHUANONG Recent Developments Table 63. CAVAC Company Information Table 64. CAVAC Business Overview Table 65. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 67. CAVAC Recent Developments Table 68. Komipharm Company Information Table 69. Komipharm Business Overview Table 70. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 72. Komipharm Recent Developments Table 73. Agrovet Company Information Table 74. Agrovet Business Overview Table 75. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 77. Agrovet Recent Developments Table 78. Bioveta Company Information Table 79. Bioveta Business Overview Table 80. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 82. Bioveta Recent Developments Table 83. JINYU BIO-TECNOLOGY CO.,LTD Company Information Table 84. JINYU BIO-TECNOLOGY CO.,LTD Business Overview Table 85. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 87. JINYU BIO-TECNOLOGY CO.,LTD Recent Developments Table 88. Phibro Animal Health Company Information Table 89. Phibro Animal Health Business Overview Table 90. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 92. Phibro Animal Health Recent Developments Table 93. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information Table 94. ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview Table 95. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 97. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments Table 98. Zoetis Company Information Table 99. Zoetis Business Overview Table 100. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 102. Zoetis Recent Developments Table 103. WINSUN BIO Company Information Table 104. WINSUN BIO Business Overview Table 105. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 107. WINSUN BIO Recent Developments Table 108. PULIKE BIOLOGICAL ENGINERING,INC. Company Information Table 109. PULIKE BIOLOGICAL ENGINERING,INC. Business Overview Table 110. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 112. PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments Table 113. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026) & (K Units) Table 115. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021-2026) Table 116. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2027-2032) & (K Units) Table 117. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2027-2032) Table 118. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021-2026) Table 120. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2027-2032) Table 122. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 124. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 125. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 129. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 130. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 139. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 140. South America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 148. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 149. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2026) Table 150. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2027-2032) Table 151. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2026) Table 154. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2027-2032) Table 155. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2026) & (USD/Unit) Table 156. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2027-2032) & (USD/Unit) Table 157. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 158. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 159. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2026) Table 160. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2027-2032) Table 161. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2026) Table 164. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2027-2032) Table 165. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2026) & (USD/Unit) Table 166. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2027-2032) & (USD/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List Table 170. Swine Reproductive and Respiratory Syndrome Vaccine Customers List Table 171. Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends Table 172. Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers Table 173. Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Swine Reproductive and Respiratory Syndrome Vaccine Product Image Figure 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit) & (2021-2032) Figure 9. Active Vaccine Product Image Figure 10. Inactivated Vaccines Product Image Figure 11. Government Tender Product Image Figure 12. Market Sales Product Image Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region in 2025 Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region in 2025 Figure 20. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country in 2025 Figure 21. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country in 2025 Figure 27. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country in 2025 Figure 40. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021-2032) Figure 42. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country in 2025 Figure 51. South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 52. South America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Colombia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country in 2025 Figure 58. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021-2032) Figure 60. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2032) Figure 66. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2032) Figure 67. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2021-2032) Figure 68. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2032) Figure 69. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2032) Figure 70. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Application (2021-2032) Figure 71. Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Figure 72. Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Active Vaccine
  • Inactivated Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • ASCENT CORPORATION
  • Boehringer-Ingelheim
  • MSD Animal Health
  • SPAH
  • Ceva
  • Chengdu TECH-BANK Biological Products Co,.Ltd
  • ringpu
  • QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  • DAHUANONG
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • JINYU BIO-TECNOLOGY CO.,LTD
  • Phibro Animal Health
  • ANHUI TIANKANG(GROUP)SHRES O., LTD
  • Zoetis
  • WINSUN BIO
  • PULIKE BIOLOGICAL ENGINERING,INC.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (2021-2032)
  5. 2.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Average Price (2021-2032)
  6. 2.3 Swine Reproductive and Respiratory Syndrome Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Active Vaccine
  9. 2.3.3 Inactivated Vaccines
  10. 2.4 Swine Reproductive and Respiratory Syndrome Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Government Tender
  13. 2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Established Date
  9. 3.9 Global Swine Reproductive and Respiratory Syndrome Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ASCENT CORPORATION
  2. 4.1.1 ASCENT CORPORATION Company Information
  3. 4.1.2 ASCENT CORPORATION Business Overview
  4. 4.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  6. 4.1.5 ASCENT CORPORATION Recent Developments
  7. 4.2 Boehringer-Ingelheim
  8. 4.2.1 Boehringer-Ingelheim Company Information
  9. 4.2.2 Boehringer-Ingelheim Business Overview
  10. 4.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  12. 4.2.5 Boehringer-Ingelheim Recent Developments
  13. 4.3 MSD Animal Health
  14. 4.3.1 MSD Animal Health Company Information
  15. 4.3.2 MSD Animal Health Business Overview
  16. 4.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  18. 4.3.5 MSD Animal Health Recent Developments
  19. 4.4 SPAH
  20. 4.4.1 SPAH Company Information
  21. 4.4.2 SPAH Business Overview
  22. 4.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  24. 4.4.5 SPAH Recent Developments
  25. 4.5 Ceva
  26. 4.5.1 Ceva Company Information
  27. 4.5.2 Ceva Business Overview
  28. 4.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  30. 4.5.5 Ceva Recent Developments
  31. 4.6 Chengdu TECH-BANK Biological Products Co,.Ltd
  32. 4.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
  33. 4.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview
  34. 4.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  36. 4.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
  37. 4.7 ringpu
  38. 4.7.1 ringpu Company Information
  39. 4.7.2 ringpu Business Overview
  40. 4.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  42. 4.7.5 ringpu Recent Developments
  43. 4.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  44. 4.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
  45. 4.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview
  46. 4.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  48. 4.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
  49. 4.9 DAHUANONG
  50. 4.9.1 DAHUANONG Company Information
  51. 4.9.2 DAHUANONG Business Overview
  52. 4.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  54. 4.9.5 DAHUANONG Recent Developments
  55. 4.10 CAVAC
  56. 4.10.1 CAVAC Company Information
  57. 4.10.2 CAVAC Business Overview
  58. 4.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  60. 4.10.5 CAVAC Recent Developments
  61. 4.11 Komipharm
  62. 4.11.1 Komipharm Company Information
  63. 4.11.2 Komipharm Business Overview
  64. 4.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  66. 4.11.5 Komipharm Recent Developments
  67. 4.12 Agrovet
  68. 4.12.1 Agrovet Company Information
  69. 4.12.2 Agrovet Business Overview
  70. 4.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  72. 4.12.5 Agrovet Recent Developments
  73. 4.13 Bioveta
  74. 4.13.1 Bioveta Company Information
  75. 4.13.2 Bioveta Business Overview
  76. 4.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  78. 4.13.5 Bioveta Recent Developments
  79. 4.14 JINYU BIO-TECNOLOGY CO.,LTD
  80. 4.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
  81. 4.14.2 JINYU BIO-TECNOLOGY CO.,LTD Business Overview
  82. 4.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  84. 4.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
  85. 4.15 Phibro Animal Health
  86. 4.15.1 Phibro Animal Health Company Information
  87. 4.15.2 Phibro Animal Health Business Overview
  88. 4.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  90. 4.15.5 Phibro Animal Health Recent Developments
  91. 4.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
  92. 4.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
  93. 4.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview
  94. 4.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  96. 4.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
  97. 4.17 Zoetis
  98. 4.17.1 Zoetis Company Information
  99. 4.17.2 Zoetis Business Overview
  100. 4.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  102. 4.17.5 Zoetis Recent Developments
  103. 4.18 WINSUN BIO
  104. 4.18.1 WINSUN BIO Company Information
  105. 4.18.2 WINSUN BIO Business Overview
  106. 4.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  108. 4.18.5 WINSUN BIO Recent Developments
  109. 4.19 PULIKE BIOLOGICAL ENGINERING,INC.
  110. 4.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
  111. 4.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Business Overview
  112. 4.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  114. 4.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
5 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Scenario by Region
  1. 5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Analysis
  2. 8.1.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process
  5. 8.2 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
  8. 8.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers
9 Global Swine Reproductive and Respiratory Syndrome Vaccine Analyzing Market Dynamics
  1. 9.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
  2. 9.2 Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers
  3. 9.3 Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges
  4. 9.4 Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst